InsiderTrades

Form 4 for RLMD RELMADA THERAPEUTICS, INC.

Accepted 2024-09-11 00:00:00 ET · period of report 2024-09-09 · accession 0001213900-24-077792 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
M 2024-09-11 2024-09-09+ RLMD Shenouda Maged CFO P - Purchase $2.80 +53.4K 64.2K +496% +$149.7K

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-09-09 P A 8,194 $2.55 43,097 D — — (F1) The number of securities reported represents an aggregate number of shares purchased in multiple open market transactions over a range of purchase prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares purchased by the Reporting Person at each separate price within the range. (F2) Purchase prices range from $2.49 to $2.60 per share, inclusive.
2 Common Common Stock 2024-09-11 P A 24,120 $2.95 88,335 D — — (F1) The number of securities reported represents an aggregate number of shares purchased in multiple open market transactions over a range of purchase prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares purchased by the Reporting Person at each separate price within the range. (F4) Purchase prices range from $2.79 to $3.05 per share, inclusive.
3 Common Common Stock 2024-09-10 P A 21,118 $2.73 64,215 D — — (F1) The number of securities reported represents an aggregate number of shares purchased in multiple open market transactions over a range of purchase prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares purchased by the Reporting Person at each separate price within the range. (F3) Purchase prices range from $2.70 to $2.75 per share, inclusive.